Achillion Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
121,850.00
152,879.00
459,341.00
363,819.00
300,074.00
270,977
Total Accounts Receivable
1,778.00
1,324.00
2,345.00
16,676.00
1,595.00
1,660
Other Current Assets
1,154.00
672.00
902.00
2,040.00
2,269.00
2,743
Total Current Assets
124,782.00
154,875.00
462,588.00
382,535.00
303,938.00
275,380
Net Property, Plant & Equipment
1,265.00
1,726.00
1,735.00
3,479.00
2,816.00
2,137
Total Investments and Advances
36,291.00
152.00
152.00
27,809.00
30,663.00
152
Other Assets
79.00
54.00
50.00
52.00
196.00
189
Total Assets
162,417.00
156,807.00
464,525.00
413,875.00
337,613.00
277,858
ST Debt & Current Portion LT Debt
291.00
195.00
223.00
351.00
170.00
Accounts Payable
4,591.00
-
4,133.00
7,002.00
5,253.00
Other Current Liabilities
4,521.00
12,864.00
10,302.00
6,618.00
7,461.00
Total Current Liabilities
9,403.00
13,059.00
14,658.00
13,971.00
12,884.00
Long-Term Debt
56.00
279.00
231.00
301.00
131.00
Other Liabilities
-
-
-
149.00
83.00
Total Liabilities
9,459.00
13,338.00
14,889.00
14,421.00
13,098.00
Common Equity (Total)
152,958.00
143,469.00
449,636.00
399,454.00
324,515.00
Total Shareholders' Equity
152,958.00
143,469.00
449,636.00
399,454.00
324,515.00
Total Equity
152,958.00
143,469.00
449,636.00
399,454.00
324,515.00
Liabilities & Shareholders' Equity
162,417.00
156,807.00
464,525.00
413,875.00
337,613.00
About Achillion Pharmaceuticals
View Profile
